Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease
NCT06324578 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2024-06-12
Summary
The main study hypothesis is that Sjögren Disease (SD), usually considered a disorder typical of adult females, may occur not exceptionally in adolescence or even in childhood as a subclinical process. There are several pieces of evidence in favor of this hypothesis, from the incidental detection of asymptomatic SD in pediatric age to biobank-based studies showing that biological signs of SD may precede the disease clinical onset by years or decades. The best scenario to verify this hypothesis could be that of autoimmune thyroiditis, for the following three reasons: 1) subjects with Autoimmune thyroiditis (AT) have a high risk of developing SD (7%); 2) in cases with comorbidity of SD and AT the diagnosis of AT had usually been made before; 3) subjects with AT routinely undergo periodic blood examination and neck ultrasonography (US), which may include Salivary Gland Ultrasound (SGUS) providing contributive data to detect an asymptomatic pre-SD. The knowledge of the real association between AT and pre-SD may impact on several aspects of medicine.
Conditions
- Sjögren
- Autoimmune Thyroid Disease
Interventions
- DIAGNOSTIC_TEST
-
AT Testing
Analysis of blood specimens and neck ultrasonography
Sponsors & Collaborators
-
IRCCS Burlo Garofolo
lead OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-25
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Italy
Study Locations
More Related Trials
-
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
NCT04931160 ·Status: RECRUITING ·Phase: NA
-
Study of Iguratimod in Sjögren's Syndrome
NCT03023592 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
NCT01008982 ·Status: COMPLETED ·Phase: PHASE2
-
Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
NCT04220034 ·Status: COMPLETED
-
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
NCT06544343 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
NCT06862284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184 ·Status: COMPLETED
-
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
NCT06245408 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pilot Feasibility Study of a Sjögren's Syndrome Self-management App
NCT04653935 ·Status: UNKNOWN ·Phase: NA
-
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
NCT06928142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies
NCT06412614 ·Status: NOT_YET_RECRUITING
-
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
NCT03348774 ·Status: UNKNOWN
-
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
NCT00968084 ·Status: COMPLETED
-
Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
NCT00632866 ·Status: COMPLETED ·Phase: PHASE3
-
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases
NCT03122431 ·Status: COMPLETED ·Phase: PHASE4
-
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
NCT06594861 ·Status: RECRUITING
-
Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases
NCT06169865 ·Status: RECRUITING
-
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
NCT04186871 ·Status: COMPLETED ·Phase: PHASE2
-
The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
NCT04558203 ·Status: COMPLETED
-
Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases
NCT01934764 ·Status: UNKNOWN
-
Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women
NCT05958446 ·Status: RECRUITING
-
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
NCT00391924 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
NCT02614716 ·Status: COMPLETED ·Phase: PHASE1
-
The ASSESS National Multi-center Prospective Cohort
NCT03040583 ·Status: RECRUITING
-
Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy
NCT02550964 ·Status: UNKNOWN